Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Hilar Cholangiocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06671418
What this trial is testing

Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

Who this might be right for
Cholangiocarcinoma Non-resectableGall Bladder CancerLiver Metastasis+1 more
Erasmus Medical Center 148
Testing effectiveness (Phase 2)UnknownNCT02162914
What this trial is testing

Regorafenib Versus Placebo to Treat Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Erasme University Hospital 66
Post-approval studies (Phase 4)UnknownNCT00746538
What this trial is testing

Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent

Who this might be right for
Unresectable Hilar Cholangiocarcinoma
Khon Kaen University 80
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Not applicableNo Longer AvailableNCT03414489
What this trial is testing

Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited
Not applicableLooking for participantsNCT06493734
What this trial is testing

Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

Who this might be right for
Klatskin Tumor
Erasmus Medical Center 30
Not applicableLooking for participantsNCT06125769
What this trial is testing

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Who this might be right for
Perihilar Cholangiocarcinoma
Azienda Sanitaria Ospedaliera 50
Not applicableLooking for participantsNCT06850753
What this trial is testing

En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

Who this might be right for
Cholangiocarcinoma Non-resectableCholangiocarcinoma RecurrentLiver Transplantation
Oslo University Hospital 15
Early research (Phase 1)WithdrawnNCT02856568
What this trial is testing

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct Cancer+10 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53